<DOC>
	<DOCNO>NCT00535366</DOCNO>
	<brief_summary>This efficacy safety study compare four different combination blind inhaled steroid treatment top open-label tiotropium salmeterol patient chronic obstructive pulmonary disease ( COPD ) . The primary objective effect lung function parameter .</brief_summary>
	<brief_title>Efficacy Safety Comparison Steroid Placebo Combination With Salmeterol Tiotropium COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Relatively stable , moderate severe COPD Male female patient 40 year age old . Current exsmokers smoke history 10 pack year Other significant disease influence study result safety risk patient Other medication influence study result Hypersensitivity study medication Patients unstable COPD</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>